These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35144588)

  • 1. Association between plasma sRAGE and emphysema according to the genotypes of AGER gene.
    Sin S; Lim MN; Kim J; Bak SH; Kim WJ
    BMC Pulm Med; 2022 Feb; 22(1):58. PubMed ID: 35144588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
    Cheng DT; Kim DK; Cockayne DA; Belousov A; Bitter H; Cho MH; Duvoix A; Edwards LD; Lomas DA; Miller BE; Reynaert N; Tal-Singer R; Wouters EF; Agustí A; Fabbri LM; Rames A; Visvanathan S; Rennard SI; Jones P; Parmar H; MacNee W; Wolff G; Silverman EK; Mayer RJ; Pillai SG;
    Am J Respir Crit Care Med; 2013 Oct; 188(8):948-57. PubMed ID: 23947473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
    Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
    Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
    Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
    Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients.
    Kinjo T; Kitaguchi Y; Droma Y; Yasuo M; Wada Y; Ueno F; Ota M; Hanaoka M
    Sci Rep; 2020 Jul; 10(1):12811. PubMed ID: 32732977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.
    Manichaikul A; Sun L; Borczuk AC; Onengut-Gumuscu S; Farber EA; Mathai SK; Zhang W; Raghu G; Kaufman JD; Hinckley-Stukovsky KD; Kawut SM; Jelic S; Liu W; Fingerlin TE; Schwartz DA; Sell JL; Rich SS; Barr RG; Lederer DJ
    Ann Am Thorac Soc; 2017 May; 14(5):628-635. PubMed ID: 28248552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis.
    Yamaguchi K; Iwamoto H; Horimasu Y; Ohshimo S; Fujitaka K; Hamada H; Mazur W; Kohno N; Hattori N
    Respirology; 2017 Jul; 22(5):965-971. PubMed ID: 28198072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.
    Miller S; Henry AP; Hodge E; Kheirallah AK; Billington CK; Rimington TL; Bhaker SK; Obeidat M; Melén E; Merid SK; Swan C; Gowland C; Nelson CP; Stewart CE; Bolton CE; Kilty I; Malarstig A; Parker SG; Moffatt MF; Wardlaw AJ; Hall IP; Sayers I
    PLoS One; 2016; 11(10):e0164041. PubMed ID: 27755550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.
    Yonchuk JG; Silverman EK; Bowler RP; Agustí A; Lomas DA; Miller BE; Tal-Singer R; Mayer RJ
    Am J Respir Crit Care Med; 2015 Oct; 192(7):785-92. PubMed ID: 26132989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for advanced glycation end products polymorphisms in coronary artery ectasia.
    Aslan EI; Ozkara G; Kilicarslan O; Ser OS; Bostan C; Yildiz A; Diren Borekcioglu A; Ozturk O; Kucukhuseyin O; Yilmaz Aydogan H
    Gene; 2024 Jul; 916():148450. PubMed ID: 38588932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in the receptor for advanced glycation end products (RAGE) gene were associated with circulating soluble RAGE level but not with renal function among Asians with type 2 diabetes: a genome-wide association study.
    Lim SC; Dorajoo R; Zhang X; Wang L; Ang SF; Tan CSH; Yeoh LY; Ng XW; Li N; Su C; Liu S; Wong MDS; Low KMS; Yao AO; Babitha J; Fun S; Zhou S; Lee SBM; Tang WE; Tavintharan S; Sum CF; Liu JJ
    Nephrol Dial Transplant; 2017 Oct; 32(10):1697-1704. PubMed ID: 27448675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating concentrations of soluble receptor for AGE are associated with age and AGER gene polymorphisms in children with newly diagnosed type 1 diabetes.
    Salonen KM; Ryhänen SJ; Forbes JM; Härkönen T; Ilonen J; Laine AP; Groop PH; Knip M;
    Diabetes Care; 2014 Jul; 37(7):1975-81. PubMed ID: 24742661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble receptor for advanced glycation end-products and progression of airway disease.
    Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
    BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
    Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
    Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
    Gaens KH; Ferreira I; van der Kallen CJ; van Greevenbroek MM; Blaak EE; Feskens EJ; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; de Groot PG; Stehouwer CD; Schalkwijk CG
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Integrative Genomic Strategy Identifies sRAGE as a Causal and Protective Biomarker of Lung Function.
    Keefe J; Yao C; Hwang SJ; Courchesne P; Lee GY; Dupuis J; Mizgerd JP; O'Connor G; Washko GR; Cho MH; Silverman EK; Levy D
    Chest; 2022 Jan; 161(1):76-84. PubMed ID: 34237330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study.
    Maruthur NM; Li M; Halushka MK; Astor BC; Pankow JS; Boerwinkle E; Coresh J; Selvin E; Kao WH
    PLoS One; 2015; 10(6):e0128452. PubMed ID: 26083729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of RAGE Polymorphic Variants in COPD Complication and Anti-COPD Therapeutic Potential of sRAGE.
    Malik P; Hoidal JR; Mukherjee TK
    COPD; 2021 Dec; 18(6):737-748. PubMed ID: 34615424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant.
    Fricke-Galindo I; García-Carmona S; Alanis-Ponce J; Pérez-Rubio G; Ramírez-Venegas A; Montiel-Lopez F; Robles-Hernández R; Hernández-Zenteno RJ; Valencia-Pérez Rea D; Bautista-Becerril B; Ramírez-Díaz ME; Cruz-Vicente F; Martínez-Gómez ML; Sansores R; Falfán-Valencia R
    Heliyon; 2024 Apr; 10(7):e28675. PubMed ID: 38571598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.